Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,795 articles
Gero is applying statistical physics to human health data to model aging rates — moving geroscience from observation to prediction.
A landmark NIH study creates the first comprehensive atlas of senescent cells, reshaping our understanding of aging biology and healthspan.
A landmark single-cell study maps how dasatinib + quercetin reshapes aging across multiple tissues, revealing timing matters as much as the drug itself.
Rare genetic defects in telomere maintenance cause premature liver aging—often misdiagnosed until advanced disease sets in.
Extracellular vesicles from uniquely regenerative deer antler stem cells cut epigenetic age by months in mice and over 2 years in macaques.
Deleting CHMP5 in bone cells triggers endolysosomal dysfunction, mitochondrial ROS, and cell senescence — causing abnormal bone growth reversible by senolytic drugs.
A comprehensive review reveals exosomes show clinical promise for aging, scarring, hair loss, and inflammatory skin conditions—but hurdles remain.
A comprehensive review reveals how exosomes from MSCs and ADSCs fight skin aging by boosting collagen, reducing inflammation, and cutting oxidative stress.
A 2026 review maps how IL-6 drives both normal kidney aging and CKD, revealing it as a potential intervention point for renal longevity.
A scoping review of 14 clinical trials finds fasting over 48 hours often increases CRP, IL-6, and TNF-α — challenging popular anti-inflammatory claims.
Discover how 'zombie cells' in your body send harmful signals that spread aging from cell to cell — and what scientists are doing to stop them.
New neurology findings link psilocybin to Alzheimer's improvements and hearing aid use to lower dementia risk across 33 countries.
